Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

Too few people get diagnosed and treated for postpartum depression. But a blood test could change that Postpartum depression ...

Recent advancements in endometriosis research are transforming treatment, focusing on non-surgical interventions and ...

Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different ...

Triple negative breast cancer accounts for 15% of cases but causes a disproportionate number of deaths. Learn about symptoms ...

Maternal stress is a major risk factor for preterm birth (PTB), with recent mouse studies highlighting the role of FKBP51 in ...

This reaction is caused by a rise in progesterone that naturally occurs during the menstrual cycle. "Progrestrogen" includes various forms of progesterone. Symptoms of the skin include rashes, hives, ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements.

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment strategies.

It would be short-sided, erroneous and dangerous to think ill of mifepristone, which has several important applications,, M.D., FACOG is an obstetrician-gynecologist in Virginia ...

We know that most endometrial cancer cells have estrogen and/or progesterone receptors on their surfaces. Somehow, interaction of these receptors and these hormones leads to increased growth of the ...